Si prevede che il mercato globale dei test ATP raggiungerà i 455,39 milioni di USD entro il 2029, rispetto ai 225,92 milioni di USD del 2020, con un CAGR dell'8,1% dal 2022 al 2029.
La crescita del mercato è principalmente guidata dalla transizione dai test basati sulla coltura ai test rapidi, dalla crescente domanda di test basati sulle cellule nella ricerca e dalla crescente necessità di test ATP nelle aziende farmaceutiche. Tuttavia, una limitazione nella distinzione tra ATP extracellulare e intracellulare pone dei vincoli all'espansione del mercato.
I progressi tecnologici hanno notevolmente migliorato la precisione della filiera alimentare . Per garantire la fornitura di prodotti di altissima qualità con rischi minimi per la salute, vari governi e aziende hanno implementato normative per definire livelli accettabili di contaminanti, residui e additivi negli alimenti. Mandati come quelli stabiliti dal Food Safety Modernization Act (FSMA) richiedono alle strutture di lavorazione alimentare di istituire protocolli di sicurezza alimentare completi e raccogliere dati quantitativi per accertare l'efficacia delle loro pratiche di pulizia e igienizzazione. Questo approccio proattivo mitiga i rischi di malattie trasmesse dagli alimenti, chiusure di strutture e richiami di prodotti, promuovendo allo stesso tempo l'efficienza operativa e riducendo i costi.
| ATTRIBUTO | DETTAGLI |
| Periodo di studio | 2020-2029 |
| Anno base | 2021 |
| Anno stimato | 2022 |
| Anno previsto | 2022-2029 |
| Periodo storico | 2018-2020 |
| Unità | Valore (miliardi di USD) |
| Segmentazione | Per prodotto, per applicazione, per utente finale, per regione. |
| Per Prodotto |
|
| Per applicazione |
|
| Per utente finale |
|
| Per regione |
|
According to the World Health Organization (WHO), in 2022, consumption of unsafe food contaminated with harmful bacteria, viruses, parasites, or chemical substances led to the occurrence of over 200 diseases, spanning from gastrointestinal disorders to cancer. An estimated 600 million individuals (nearly 1 in 10 people worldwide) experience illness after consuming tainted food, resulting in approximately 420,000 fatalities annually and a loss of 33 million healthy life years (DALYs).
ATP serves as a universal mediator of metabolism and signaling across both unicellular and multicellular organisms. The intricate interplay between ATP dynamics and cellular physiology extends from intracellular to extracellular levels. Consequently, elucidating and comprehending ATP dynamics yields invaluable mechanistic insights into diverse biological processes, ranging from neurotransmission to immune cell chemotaxis. Consequently, there exists a pressing need for methodologies capable of examining both the temporal and spatial aspects of ATP dynamics across various scales, from subcellular to organismal levels, in live specimens.
The ATP assays market size had crossed USD 225,92 Billion in 2020 and will observe a CAGR of more than 8.1% up to 2029 driven by the rising increasing food safety concerns.
The upcoming trend in ATP assays market is a technological enhancement in ATP assay probes is an opportunity for market growth.
The global ATP assays market registered a CAGR of 8.1% from 2022 to 2029. The product segment was the highest revenue contributor to the market.
Key players profiled in the report include Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, NEOGEN Corporation, 3M, Danaher Corporation, PromoCell GmbH, Geno Technology, Inc., Abnova Corporation, AAT Bioquest, BioThema AB, Elabscience Biotechnology Inc.
Contamination testing segment dominate the application of ATP assays market.
North America is the largest regional market with 43% of share The rising incidence and prevalence of chronic and infectious diseases, rising demand for cell-based assays in research.
The ATP assays market is divided into consumables & accessories, reagent, microplates, other consumables & accessories, instruments, luminometers, spectrophotometers based on product. Consumables & accessories segment dominate the market. The large share of the consumables and accessories segment can be attributed to the widespread use of ATP assays in research institutes to measure cell viability, an increase in drug discovery due to an increase in chronic diseases that necessitate tumour testing and cell proliferation (in cancer), and pharmaceutical and biotechnology companies' repeated purchases of consumables.
The market is divided into contamination testing, disease testing, drug discovery and development based on application. Contamination testing segment dominate the market. The rising regulatory stringency of pharmaceutical and food & beverage companies for non-contaminated production, an increase in drug discovery post COVID-19, and the need for cleaning and disinfection of environmental surfaces in hospitals are all contributing to the contamination testing segment's large share.
The market is divided into pharmaceutical & biotechnology companies, food and beverage industry, hospitals and diagnostic laboratories, academic and research institutions based on end user. Pharmaceutical & biotechnology segment dominate the market. The presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines that require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, increasing demand for cell and gene therapies for chronic diseases, and significant R&D in pharmaceutical and biotechnology can all be attributed to the pharmaceutical and biotechnology segment's large share.
[caption id="attachment_9060" align="alignnone" width="680"]
The major players operating in the global ATP assays industry include Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, NEOGEN Corporation, 3M, Danaher Corporation, PromoCell GmbH, Geno Technology, Inc., Abnova Corporation, AAT Bioquest, BioThema AB, Elabscience Biotechnology Inc., MBL International Corporation, Biotium, and Creative Bioarray. The presence of established industry players and is characterized by mergers and acquisitions, joint ventures, capacity expansions, substantial distribution, and branding decisions to improve market share and regional presence. Also, they are involved in continuous R&D activities to develop new products as well as are focused on expanding the product portfolio. This is expected to intensify competition and pose a potential threat to the new players entering the market.
Geographically, the ATP assays market is segmented into North America, South America, Europe, APAC and MEA.
North America is expected to hold the largest share of the global ATP assays market. The rising incidence and prevalence of chronic and infectious diseases, rising demand for cell-based assays in research, increasing focus on cell-based therapeutics, favourable government support for research, and the presence of high-quality infrastructure for clinical and laboratory research in the region are all factors contributing to North America's large share.
[caption id="attachment_9063" align="alignleft" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.